Partnership expansion FORWARD's collaboration with Alira Health signals readiness to scale registry operations and offer expanded analytics and reporting offerings to pharmaceutical, biopharma, and research partners.

RWE monetization The organization maintains a rich patient-reported data resource ideal for real-world evidence studies, outcomes analysis, and cost-of-illness work, presenting a clear sales path for data access licenses and custom reports to industry and research clients.

Multi-stakeholder opportunities With governance that includes patients, clinicians, researchers, and industry partners, FORWARD can link sponsors to recruitment, engagement programs, sponsored research, and collaborative studies that leverage its registry and analytics capabilities.

Secure cloud platform A modern cloud-based, privacy-conscious IT stack supports scalable data sharing, compliant reporting, and secure analytics delivery, a strong differentiator when engaging enterprise customers seeking reliable real-world data.

Non-profit credibility As a long-running, independent research databank with strong academic and patient-community ties, FORWARD offers trust and legitimacy for funders and partners pursuing socially impactful research and co-funded initiatives.